Skip to content
Search

Latest Stories

The ESG revolution: A healthy dose for pharmacies

The ESG revolution: A healthy dose for pharmacies

Tarina Shah and Jayasri Prasad of Sinequanon Consulting highlight the importance of ESG adoption and offer actionable steps to start implementation…

The business landscape worldwide is undergoing a significant transformation, shifting from a sole focus on profitability to incorporating a broader spectrum of considerations. Today, Environmental, Social, and Governance (ESG) criteria are integral to business operations, reflecting a commitment to sustainable and ethical practices alongside financial growth.


ESG stands for three interconnected pillars: Environmental, focusing on reducing a company's ecological footprint; Social, addressing the impact on employees, diversity, equity, inclusion, and the broader community; and Governance, which ensures responsible management practices, ethical behavior, and compliance with regulations.

This holistic approach is becoming a critical foundation for long-term success in various industries, including healthcare. For the UK healthcare and pharmacy sectors, integrating ESG not only aligns with global sustainability goals but also offers substantial benefits. This article delves into the specific implications of ESG for UK pharmacies, highlighting how they can leverage these practices to foster both community well-being and business success.

Why is ESG Such a Big Deal?

Firstly, environmental concerns are more critical than ever. Climate change, resource scarcity, and pollution are urgent issues that demand immediate and decisive action. Consumers, investors, and regulators are increasingly holding companies accountable for their environmental impact.

Secondly, social responsibility has moved from a peripheral to a central concern for businesses. Issues such as diversity, equity, and inclusion (DE&I), fair labor practices, and employee well-being are becoming priorities. Consumers are more likely to support companies that align with their values and treat their workforce ethically.

Finally, strong corporate governance is crucial for building trust and ensuring long-term stability. Transparent decision-making, robust risk management, and ethical leadership are key. Investors are particularly drawn to companies with solid governance practices as these help mitigate financial risks and foster sustainable growth.

Moreover, these factors are closely tied to broader national and international commitments, such as the UK’s pledge to achieve net zero emissions and its commitment to the Sustainable Development Goals (SDGs). These 17 goals emphasise the global agenda towards sustainable development that balances social equity, environmental health, and economic growth. In the UK, these priorities percolate through public agencies like the NHS, influencing expectations and operational frameworks down to the level of individual pharmacies.

ESG: A Winning Formula for Pharmacies

Embracing ESG is not just the responsible thing to do; it's also a sound business decision for UK pharmacies. Here's why:

  • Enhanced Reputation and Brand Loyalty: Consumers are increasingly making informed choices based on a company's ESG commitment. Strong ESG practices demonstrate a pharmacy's dedication to social responsibility and environmental well-being, leading to a positive brand image and attracting socially conscious customers.
  • Access to Capital: A strong ESG profile enhances a pharmacy's brand image and reputation. This attracts customers who value responsible businesses and can lead to increased customer loyalty. Additionally, investors are increasingly looking to invest in companies with strong ESG practices, which can translate to improved access to capital and financing for pharmacies looking to grow or expand.
  • Improved Cost Management: Focusing on energy efficiency, waste reduction, and responsible sourcing can generate substantial cost savings. Additionally, strong governance practices can minimize regulatory risks and associated financial penalties.
  • Attract and Retain Talent: Millennials and Gen Z, who are now entering the workforce in greater numbers, prioritize working for companies committed to social responsibility and sustainability. A robust ESG strategy can be a key differentiator in attracting and retaining top talent within the pharmacy sector.
  • Future-Proofing the Business: Climate change regulations, resource scarcity, and evolving consumer expectations necessitate a focus on sustainability. By proactively addressing ESG challenges, pharmacies can ensure their long-term viability and success in a rapidly evolving healthcare landscape.

Making ESG a Reality: Practical Steps for UK Pharmacies

While the importance of ESG is clear, putting it into practice can seem daunting. Here are some actionable steps pharmacies can take to get started:

  • Environmental Initiatives: Implement energy-efficient lighting fixtures and HVAC systems. Reduce packaging waste by offering refillable options or partnering with suppliers that use eco-friendly packaging materials. Ensure responsible disposal of inhalers and anesthetics, which often contain high-emission greenhouse gases or pollutants. Explore programmes that can properly recycle or reclaim these materials.
  • Social Initiatives: Offer competitive compensation packages and promote work-life balance for employees. Foster a diverse and inclusive workplace culture that values inclusivity and equal opportunity. Partner with local community organisations to promote public health initiatives and medication adherence programs.
  • Governance Initiatives: Implement robust policies and procedures for ethical conduct and compliance. Ensure strong board oversight and transparency in decision-making. Regularly review and update your ESG strategy to reflect evolving needs and regulations.

By embracing ESG, UK pharmacies can become key players in shaping a healthier future. This approach benefits the environment, fosters a more responsible and sustainable healthcare system, and ultimately, creates a stronger and more successful pharmacy business. It's a win-win-win situation for pharmacies, the environment, and the communities they serve. Take the ESG prescription and watch your pharmacy thrive in the years to come.

Authors 

Tarina Shah, Director and Head of Social Impact at Sinequanon Consulting & Director at Joynetix Ltd, and Jayasri Prasad, CEO of Sinequanon Consulting 

More For You

Walgreens Boots Alliance acquired by Sycamore in deal

Walgreens Boots Alliancehas entered into “a definitive agreement” to be acquired by Sycamore Partners

Gettyimages

Walgreens Boots Alliance acquired by Sycamore in £18.3 billion deal

Walgreens Boots Alliance(WBA) has entered into “a definitive agreement” to be acquired by Sycamore Partners, a private equity firm specializing in retail, consumer and distribution-related investments.

“The total value of the transaction represents up to $23.7 billion (£18.3 billion),” the company announced late last night (6).

Keep ReadingShow less
Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
National Insurance Contributions rise to 15%: What it means for community pharmacies

From April 2025, the Employers’ National Insurance Contributions will rise to 15%.

gettyimages

Understanding the changes to National Insurance Contributions

The Autumn statement from the Chancellor was brutal for employers to say the least. The employer's National Insurance Contributions (NIC) is estimated to cost businesses c£25bn per annum from April 2025 onwards.

We cover the main points here:

Keep ReadingShow less